We Think Aier Eye Hospital Group (SZSE:300015) Can Manage Its Debt With Ease
We Think Aier Eye Hospital Group (SZSE:300015) Can Manage Its Debt With Ease
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We can see that Aier Eye Hospital Group Co., Ltd. (SZSE:300015) does use debt in its business. But is this debt a concern to shareholders?
David Iben说得很好,'波动性不是我们关心的风险。我们关心的是避免永久性资本损失。' 当我们考虑一家公司有多大风险时,我们总是喜欢看其使用债务,因为债务过载可能导致灭亡。我们可以看到爱尔眼科(SZSE:300015)确实在业务中使用债务。但这笔债务会让股东担忧吗?
Why Does Debt Bring Risk?
为什么债务会带来风险?
Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. When we examine debt levels, we first consider both cash and debt levels, together.
一般来说,只有当公司不能轻易地用自己的现金流或筹集资金偿还债务时,债务才会成为一个真正的问题。最终,如果公司无法履行偿还债务的法律义务,股东可能会一无所有。然而,更频繁(但仍然代价高昂)的情况是,公司必须以低于市价的价格发行股票,永久性地稀释股东的权益,以加强其资产负债表。话虽如此,最常见的情况是公司合理地管理其债务,并以自己的优势管理。当我们分析债务水平时,首先要考虑现金和债务水平,二者结合起来。
What Is Aier Eye Hospital Group's Debt?
爱尔眼科集团的债务是多少?
The image below, which you can click on for greater detail, shows that at September 2024 Aier Eye Hospital Group had debt of CN¥1.66b, up from CN¥1.12b in one year. But on the other hand it also has CN¥5.57b in cash, leading to a CN¥3.91b net cash position.
下面的图像显示,您可以点击以获取更多详细信息,显示到2024年9月,爱尔眼科集团的债务为16.6亿人民币,比一年前的11.2亿人民币增加。但另一方面,它也有55.7亿人民币的现金,导致净现金位置为39.1亿人民币。

How Strong Is Aier Eye Hospital Group's Balance Sheet?
爱尔眼科集团的资产负债表有多坚固?
We can see from the most recent balance sheet that Aier Eye Hospital Group had liabilities of CN¥6.68b falling due within a year, and liabilities of CN¥4.76b due beyond that. Offsetting these obligations, it had cash of CN¥5.57b as well as receivables valued at CN¥2.22b due within 12 months. So it has liabilities totalling CN¥3.65b more than its cash and near-term receivables, combined.
我们从最近的资产负债表中可以看到,爱尔眼科集团有660亿人民币的短期到期负债,以及47.6亿人民币的长期到期负债。抵消这些义务的是,它拥有55.7亿人民币的现金以及价值22.2亿人民币的应收账款,其中12个月内到期。因此,其负债总额比其现金和短期应收账款合计高36.5亿人民币。
Given Aier Eye Hospital Group has a humongous market capitalization of CN¥140.3b, it's hard to believe these liabilities pose much threat. But there are sufficient liabilities that we would certainly recommend shareholders continue to monitor the balance sheet, going forward. Despite its noteworthy liabilities, Aier Eye Hospital Group boasts net cash, so it's fair to say it does not have a heavy debt load!
鉴于爱尔眼科集团市值高达1403亿人民币,很难相信这些负债会构成重大威胁。但我们必定建议股东继续关注资产负债表的变化。尽管有显著负债,爱尔眼科集团拥有净现金,因此可以说其负债并不重。
Aier Eye Hospital Group's EBIT was pretty flat over the last year, but that shouldn't be an issue given the it doesn't have a lot of debt. There's no doubt that we learn most about debt from the balance sheet. But ultimately the future profitability of the business will decide if Aier Eye Hospital Group can strengthen its balance sheet over time. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.
过去一年,爱尔眼科集团的EBIt基本持平,但考虑到其并没有太多债务,这应该不是问题。毫无疑问,我们从资产负债表上了解到债务的情况最多。但最终业务的未来盈利能力将决定爱尔眼科集团是否能够随着时间加强其资产负债表。因此,如果您想了解专业人士的看法,您可能会发现分析师盈利预测的这份免费报告很有趣。
Finally, a company can only pay off debt with cold hard cash, not accounting profits. While Aier Eye Hospital Group has net cash on its balance sheet, it's still worth taking a look at its ability to convert earnings before interest and tax (EBIT) to free cash flow, to help us understand how quickly it is building (or eroding) that cash balance. During the last three years, Aier Eye Hospital Group produced sturdy free cash flow equating to 76% of its EBIT, about what we'd expect. This free cash flow puts the company in a good position to pay down debt, when appropriate.
最后,一家公司只能用冷硬现金来偿还债务,而不能用会计利润。尽管爱尔眼科集团在资产负债表上有净现金,但仍值得注意其将息税前利润(EBIT)转化为自由现金流的能力,以帮助我们了解其建立(或侵蚀)现金余额的速度。在过去三年中,爱尔眼科集团产生了坚实的自由现金流,相当于其EBIt的76%,这正是我们所期望的。这笔自由现金流使公司有能力在适当时偿还债务。
Summing Up
总之
We could understand if investors are concerned about Aier Eye Hospital Group's liabilities, but we can be reassured by the fact it has has net cash of CN¥3.91b. The cherry on top was that in converted 76% of that EBIT to free cash flow, bringing in CN¥2.9b. So is Aier Eye Hospital Group's debt a risk? It doesn't seem so to us. When analysing debt levels, the balance sheet is the obvious place to start. However, not all investment risk resides within the balance sheet - far from it. For example Aier Eye Hospital Group has 2 warning signs (and 1 which is a bit unpleasant) we think you should know about.
我们可以理解投资者对爱尔眼科集团的负债感到担忧,但我们可以放心的是,它的净现金为人民币39.1亿。再加上它将76%的EBIT转化为自由现金流,带来了29亿人民币。那么爱尔眼科集团的债务是否存在风险呢?在我们看来,并非如此。在分析债务水平时,资产负债表是开始的明显地方。然而,并非所有的投资风险都集中在资产负债表中,远非如此。例如,爱尔眼科集团有2个警示信号(其中有1个不太愉快),我们认为你应该知道。
At the end of the day, it's often better to focus on companies that are free from net debt. You can access our special list of such companies (all with a track record of profit growth). It's free.
每天结束时,通常更好地关注那些没有净债务的公司。您可以查看我们特别名单上的这些公司(所有这些公司都有盈利增长记录)。这是免费的。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。